Community-acquired pneumonia.

A 67-year-old woman with mild Alzheimer’s disease who has a 2-day history of productive cough, fever, and increased confusion is transferred from a nursing home to the emergency department. According to the transfer records, she has had no recent hospitalizations or recent use of antibiotic agents. Her temperature is 38.4°C (101°F), the blood pressure is 145/85 mm Hg, the respiratory rate is 30 breaths per minute, the heart rate is 120 beats per minute, and the oxygen saturation is 91% while she is breathing ambient air. Crackles are heard in both lower lung fields. She is oriented to person only. The white-cell count is 4000 per cubic millimeter, the serum sodium level is 130 mmol per liter, and the blood urea nitrogen is 25 mg per deciliter (9.0 mmol per liter). A radiograph of the chest shows infiltrates in both lower lobes. How and where should this patient be treated?

[1]  D. Musher,et al.  Clinical Diagnosis, Viral PCR, and Antibiotic Utilization in Community-Acquired Pneumonia , 2016, American journal of therapeutics.

[2]  E. Barrett-Connor The nonvalue of sputum culture in the diagnosis of pneumococcal pneumonia. , 2015, The American review of respiratory disease.

[3]  D. Musher,et al.  Clinical prediction rules in community-acquired pneumonia: lies, damn lies and statistics. , 2014, QJM : monthly journal of the Association of Physicians.

[4]  M. Fine,et al.  Association of azithromycin with mortality and cardiovascular events among older patients hospitalized with pneumonia. , 2014, JAMA.

[5]  Á. Gentile [U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination]. , 2014, Archivos argentinos de pediatria.

[6]  T. File,et al.  Distribution of 13-valent pneumococcal conjugate vaccine Streptococcus pneumoniae serotypes in US adults aged ≥50 years with community-acquired pneumonia. , 2013, The Journal of infectious diseases.

[7]  K. Baumstarck,et al.  Effect of statin therapy on mortality in patients with ventilator-associated pneumonia: a randomized clinical trial. , 2013, JAMA.

[8]  J. Rello,et al.  Microbial aetiology of healthcare associated pneumonia in Spain: a prospective, multicentre, case–control study , 2013, Thorax.

[9]  Z. Memish,et al.  Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study , 2013, The Lancet Infectious Diseases.

[10]  Jian He,et al.  Clinical findings in 111 cases of influenza A (H7N9) virus infection. , 2013, The New England journal of medicine.

[11]  M. Kollef,et al.  Azithromycin and survival in Streptococcus pneumoniae pneumonia: a retrospective study , 2013, BMJ Open.

[12]  E. Walsh,et al.  Bacterial Complications of Respiratory Tract Viral Illness: A Comprehensive Evaluation , 2013, The Journal of infectious diseases.

[13]  D. Musher,et al.  Long-term survival following pneumococcal pneumonia. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  K. O'Brien,et al.  Estimating the Burden of Pneumococcal Pneumonia among Adults: A Systematic Review and Meta-Analysis of Diagnostic Techniques , 2013, PloS one.

[15]  D. Musher,et al.  Can an etiologic agent be identified in adults who are hospitalized for community-acquired pneumonia: Results of a one-year study , 2013, Journal of Infection.

[16]  T. Wiemken,et al.  Clinical scoring tools: which is best to predict clinical response and long-term outcomes? , 2013, Infectious disease clinics of North America.

[17]  L. Mandell,et al.  Guidelines and quality measures: do they improve outcomes of patients with community-acquired pneumonia? , 2013, Infectious disease clinics of North America.

[18]  M. Postma,et al.  The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysis , 2013, European Journal of Clinical Microbiology & Infectious Diseases.

[19]  T. File,et al.  Determining the Duration of Therapy for Patients with Community-Acquired Pneumonia , 2013, Current Infectious Disease Reports.

[20]  W. Boersma,et al.  Diagnostic accuracy of a serotype-specific antigen test in community-acquired pneumonia , 2013, European Respiratory Journal.

[21]  John Holden,et al.  Vaccines for preventing pneumococcal infection in adults. , 2013, The Cochrane database of systematic reviews.

[22]  Leora I. Horwitz,et al.  Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia. , 2013, JAMA.

[23]  A. Pavia What is the Role of Respiratory Viruses in Community-Acquired Pneumonia? , 2012, Infectious Disease Clinics of North America.

[24]  J. Hedlund,et al.  Swedish guidelines on the management of community-acquired pneumonia in immunocompetent adults—Swedish Society of Infectious Diseases 2012 , 2012, Scandinavian journal of infectious diseases.

[25]  D. Bratzler,et al.  Predictors of in-hospital vs postdischarge mortality in pneumonia. , 2012, Chest.

[26]  E. Calbo,et al.  Aetiology of community-acquired pneumonia among adults in an H1N1 pandemic year: the role of respiratory viruses , 2012, European Journal of Clinical Microbiology & Infectious Diseases.

[27]  Madhukar Pai,et al.  Accuracy of Rapid Influenza Diagnostic Tests , 2012, Annals of Internal Medicine.

[28]  S. Madhi,et al.  Use of a rapid test of pneumococcal colonization density to diagnose pneumococcal pneumonia. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  M. Fine,et al.  Cardiac Complications in Patients With Community-Acquired Pneumonia: Incidence, Timing, Risk Factors, and Association With Short-Term Mortality , 2012, Circulation.

[30]  K. Ko,et al.  Changing Trends in Antimicrobial Resistance and Serotypes of Streptococcus pneumoniae Isolates in Asian Countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study , 2012, Antimicrobial Agents and Chemotherapy.

[31]  Carrie L. Byington,et al.  FilmArray, an Automated Nested Multiplex PCR System for Multi-Pathogen Detection: Development and Application to Respiratory Tract Infection , 2011, PloS one.

[32]  R. E. Cunningham,et al.  Autopsy series of 68 cases dying before and during the 1918 influenza pandemic peak , 2011, Proceedings of the National Academy of Sciences.

[33]  A. Akram,et al.  Validation of the Infectious Diseases Society of America/American Thoratic Society minor criteria for intensive care unit admission in community-acquired pneumonia patients without major criteria or contraindications to intensive care unit care. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  D. Musher,et al.  Immunomodulatory agents in the treatment of community-acquired pneumonia: a systematic review. , 2011, The Journal of infection.

[35]  J. Oosterheert,et al.  Cause-specific long-term mortality rates in patients recovered from community-acquired pneumonia as compared with the general Dutch population. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[36]  C. Esquinas,et al.  Microbial aetiology of community-acquired pneumonia and its relation to severity , 2011, Thorax.

[37]  L. Gubareva,et al.  Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2011, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[38]  T. File,et al.  Integrated analysis of FOCUS 1 and FOCUS 2: randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community-acquired pneumonia. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[39]  C. Frei,et al.  Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit. , 2010, Clinical therapeutics.

[40]  D. Musher,et al.  Role of acute infection in triggering acute coronary syndromes. , 2010, The Lancet. Infectious diseases.

[41]  J. Hedlund,et al.  Etiology of Community-Acquired Pneumonia: Increased Microbiological Yield with New Diagnostic Methods , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[42]  J. Oosterheert,et al.  Pneumonia Recovery; Discrepancies in Perspectives of the Radiologist, Physician and Patient , 2009, Journal of General Internal Medicine.

[43]  S. Fukuhara,et al.  Systematic review and metaanalysis: urinary antigen tests for Legionellosis. , 2009, Chest.

[44]  Liam Smeeth,et al.  Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. , 2009, The Lancet. Infectious diseases.

[45]  W. Lim,et al.  BTS guidelines for the management of community acquired pneumonia in adults: update 2009 , 2009, Thorax.

[46]  Angela H Hogan,et al.  Diagnosis of Streptococcus pneumoniae Infections in Adults with Bacteremia and Community-Acquired Pneumonia: Clinical Comparison of Pneumococcal PCR and Urinary Antigen Detection , 2009, Journal of Clinical Microbiology.

[47]  M. Christ-Crain,et al.  Clinical predictors for Legionella in patients presenting with community-acquired pneumonia to the emergency department , 2009, BMC pulmonary medicine.

[48]  J. M. Porcel,et al.  Risk factors and outcome of community‐acquired pneumonia due to Gram‐negative bacilli , 2009, Respirology (Carlton South. Print).

[49]  J. Fox,et al.  Viral Infection in Adults Hospitalized With Community-Acquired Pneumonia , 2008, Chest.

[50]  T. Marrie,et al.  Long-Term Morbidity and Mortality After Hospitalization With Community-Acquired Pneumonia: A Population-Based Cohort Study , 2008, Medicine.

[51]  J. Ramirez,et al.  Acute myocardial infarction in hospitalized patients with community-acquired pneumonia. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[52]  A. Anzueto,et al.  A comparative study of community-acquired pneumonia patients admitted to the ward and the ICU. , 2008, Chest.

[53]  J. McCue,et al.  Antibiotic timing and errors in diagnosing pneumonia. , 2008, Archives of internal medicine.

[54]  J. Raboud,et al.  Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[55]  D. Boulware,et al.  Rapid diagnosis of pneumococcal pneumonia among HIV-infected adults with urine antigen detection. , 2007, The Journal of infection.

[56]  D. Moore,et al.  Efficacy of short-course antibiotic regimens for community-acquired pneumonia: a meta-analysis. , 2007, The American journal of medicine.

[57]  D. Musher,et al.  The association between pneumococcal pneumonia and acute cardiac events. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[58]  V. Zarubaev,et al.  Clinical Research , 2022 .

[59]  J. Bartlett,et al.  Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[60]  M. Kanwar,et al.  Misdiagnosis of community-acquired pneumonia and inappropriate utilization of antibiotics: side effects of the 4-h antibiotic administration rule. , 2006, Chest.

[61]  M. Christ-Crain,et al.  Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. , 2006, American journal of respiratory and critical care medicine.

[62]  C. Weenink,et al.  Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study , 2006, BMJ : British Medical Journal.

[63]  M. Bonten,et al.  Impact of Rapid Detection of Viral and Atypical Bacterial Pathogens by Real-Time Polymerase Chain Reaction for Patients with Lower Respiratory Tract Infection , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[64]  S. Richter,et al.  Antimicrobial resistance among Streptococcus pneumoniae in the United States: have we begun to turn the corner on resistance to certain antimicrobial classes? , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[65]  L. Alemany,et al.  Sensitivity of urinary antigen test in relation to clinical severity in a large outbreak of Legionella pneumonia in Spain , 2005, European Journal of Clinical Microbiology and Infectious Diseases.

[66]  D. Musher,et al.  Diagnostic value of microscopic examination of Gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[67]  M. García-nuñez,et al.  Comparative Study of Community-Acquired Pneumonia Caused by Streptococcus pneumoniae, Legionella pneumophila or Chlamydia pneumoniae , 2004, Scandinavian journal of infectious diseases.

[68]  J. Xiang,et al.  Efficacy of 750-mg, 5-day levofloxacin in the treatment of community-acquired pneumonia caused by atypical pathogens , 2004, Current medical research and opinion.

[69]  L. Mandell,et al.  Short-course treatment of community-acquired pneumonia. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[70]  T. Avšič-Županc,et al.  Aetiology and Clinical Presentation of Mild Community-Acquired Bacterial Pneumonia , 2003, European Journal of Clinical Microbiology and Infectious Diseases.

[71]  Jordi Carratalà,et al.  Clinical diagnosis of Legionella pneumonia revisited: evaluation of the Community-Based Pneumonia Incidence Study Group scoring system. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[72]  W. Lim,et al.  Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study , 2003, Thorax.

[73]  G. Royo,et al.  Evaluation of the immunochromatographic Binax NOW assay for detection of Streptococcus pneumoniae urinary antigen in a prospective study of community-acquired pneumonia in Spain. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[74]  J. Liao,et al.  Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[75]  S. Ōmura,et al.  Erythromycin suppresses nuclear factor-kappaB and activator protein-1 activation in human bronchial epithelial cells. , 2000, Biochemical and biophysical research communications.

[76]  M. Fine,et al.  Influence of age on symptoms at presentation in patients with community-acquired pneumonia. , 1997, Archives of internal medicine.

[77]  M. Fine,et al.  Measuring symptomatic and functional recovery in patients with community-acquired pneumonia , 1997, Journal of General Internal Medicine.

[78]  M. Fine,et al.  A prediction rule to identify low-risk patients with community-acquired pneumonia. , 1997, The New England journal of medicine.

[79]  D. Thévenin,et al.  Severe community-acquired pneumonia in ICUs: Prospective validation of a prognostic score , 1996, Intensive Care Medicine.

[80]  C A Britton,et al.  Interobserver reliability of the chest radiograph in community-acquired pneumonia. PORT Investigators. , 1996, Chest.

[81]  Richard D Moore,et al.  Community-acquired pneumonia: impact of immune status. , 1995 .

[82]  M. Cetron,et al.  The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. , 1995, The New England journal of medicine.

[83]  C. Cabellos,et al.  Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. , 1995, The New England journal of medicine.

[84]  J E Heffner,et al.  Pleural fluid chemical analysis in parapneumonic effusions. A meta-analysis. , 1995, American journal of respiratory and critical care medicine.

[85]  T. Quinn,et al.  Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[86]  J. Hermans,et al.  Efficacy and safety of azithromycin versus benzylpenicillin or erythromycin in community-acquired pneumonia , 1995, European Journal of Clinical Microbiology and Infectious Diseases.

[87]  R. Austrian Confronting Drug-resistant Pneumococci , 1994, Annals of Internal Medicine.

[88]  T. Marrie [Community acquired pneumonia]. , 1994, Praxis.

[89]  V L Yu,et al.  Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association. , 1993 .

[90]  S. Sahn Management of complicated parapneumonic effusions. , 1993, The American review of respiratory disease.

[91]  V. Yu,et al.  Is pneumonia really the old man's friend? Two-year prognosis after community-acquired pneumonia , 1993, The Lancet.

[92]  I. Brook,et al.  Aerobic and anaerobic microbiology of empyema. A retrospective review in two military hospitals. , 1993, Chest.

[93]  D. Barnes Microbial etiology of acute pneumonia in hospitalized patients. , 1993, Chest.

[94]  M. Fine,et al.  Validation of a pneumonia prognostic index using the MedisGroups Comparative Hospital Database. , 1993, The American journal of medicine.

[95]  Glen A. Satten,et al.  HIV Infection among Patients in U.S. Acute Care Hospitals , 1992 .

[96]  G. Kinasewitz,et al.  Azithromycin versus cefaclor in the treatment of acute bacterial pneumonia , 1991, European Journal of Clinical Microbiology and Infectious Diseases.

[97]  M. Fisch,et al.  Predicting death in patients hospitalized for community-acquired pneumonia. , 1991, Annals of internal medicine.

[98]  R. Rodríguez-Roisín,et al.  Severe community-acquired pneumonia. Epidemiology and prognostic factors. , 1991, The American review of respiratory disease.

[99]  M. Fine,et al.  Hospitalization decision in patients with community-acquired pneumonia: a prospective cohort study. , 1990, The American journal of medicine.

[100]  M. Niederman,et al.  Utility of fiberoptic bronchoscopy in nonresolving pneumonia. , 1990, Chest.

[101]  W. Kapoor,et al.  New and Emerging Etiologies for Community‐Acquired Pneumonia with Implications for Therapy: A Prospective Multicenter Study of 359 Cases , 1990, Medicine.

[102]  E. Block,et al.  Clinical role of bronchoalveolar lavage in adults with pulmonary disease. , 1990, The American review of respiratory disease.

[103]  D. Kaiser,et al.  Prediction of microbial aetiology at admission to hospital for pneumonia from the presenting clinical features. British Thoracic Society Pneumonia Research Subcommittee. , 1989, Thorax.

[104]  T. Marrie,et al.  Community-acquired pneumonia requiring hospitalization: 5-year prospective study. , 1989, Reviews of infectious diseases.

[105]  R. Lumb,et al.  A prospective hospital study of the aetiology of community‐acquired pneumonia , 1989, The Medical journal of Australia.

[106]  R. Garibaldi,et al.  Epidemiology of community-acquired respiratory tract infections in adults , 1985, The American Journal of Medicine.

[107]  P. Dans,et al.  Management of pneumonia in the prospective payment era. A need for more clinician and support service interaction. , 1984, Archives of internal medicine.

[108]  A. Esposito Community-acquired bacteremic pneumococcal pneumonia. Effect of age on manifestations and outcome. , 1984, Archives of internal medicine.

[109]  R. Larsen,et al.  Diagnosis of community-acquired pneumonia: experience at a community hospital. , 1984, Comprehensive therapy.

[110]  J. Bass,et al.  Diagnosis of bacterial pulmonary infections with quantitative protected catheter cultures obtained during bronchoscopy , 1983, Journal of clinical microbiology.

[111]  G. Warr,et al.  Alveolar macrophage ingestion and phagosome-lysosome fusion defect associated with virus pneumonia. , 1980, Infection and immunity.

[112]  R. Light,et al.  Cefazolin vs penicillin. Treatment of uncomplicated pneumococcal pneumonia. , 1979, JAMA.

[113]  C. Helms,et al.  Comparative features of pneumococcal, mycoplasmal, and Legionnaires' disease pneumonias. , 1979, Annals of internal medicine.

[114]  R. Jennings,et al.  Accuracy of Gram's stain in identifying pneumococci in sputum. , 1978, JAMA.

[115]  D. Musher,et al.  INFECTIONS DUE TO STAPHYLOCOCCUS AUREUS , 1977, Medicine.

[116]  S. Jay,et al.  The radiographic resolution of Streptococcus pneumoniae pneumonia. , 1975, The New England journal of medicine.

[117]  S. G. Farmer,et al.  Etiologies and characteristic features of pneumonias in a municipal hospital , 1973, The American journal of the medical sciences.

[118]  W. Dowdle,et al.  Adult pneumonia in a general hospital. Etiology and host risk factors. , 1972, Archives of internal medicine.

[119]  D. Gump,et al.  Bacteria, viruses, and mycoplasmas in acute pneumonia in adults. , 1971, The American review of respiratory disease.

[120]  A. Bisno,et al.  Pneumonia and Hong Kong influenza: a prospective study of the 1968-1969 epidemic , 1971, The American journal of the medical sciences.

[121]  A. Wicks,et al.  One-day treatment for lobar pneumonia , 1970, Thorax.

[122]  P. Hoeprich Etiologic diagnosis of lower respiratory tract infections. , 1970, California medicine.

[123]  R. Chanock,et al.  The role of viruses, mycoplasmas and bacteria in acute pneumonia in civilian adults. , 1967, American journal of epidemiology.

[124]  R. H. Parker,et al.  Diagnostic usefulness and safety of transtracheal aspiration. , 1967, The New England journal of medicine.

[125]  G. Kenny,et al.  Epidemiology of Mycoplasma pneumoniae infection in families. , 1966, JAMA.

[126]  E. H. Townsend,et al.  Pneumococcic Segmental (Lobar) Pneumonia , 1965, Clinical pediatrics.

[127]  R. Austrian,et al.  THE EFFICACY OF PENICILLIN V (PHENOXYMETHYLPENICILLIN) IN THE TREATMENT OF MILD AND OF MODERATELY SEVERE PNEUMOCOCCAL PNEUMONIA , 1956, The American journal of the medical sciences.

[128]  J. Bullowa,et al.  The Reliability of Sputum Typing and its Relation to Serum Therapy. , 1935 .

[129]  H. Svanström,et al.  Cardiovascular risks with azithromycin. , 2013, The New England journal of medicine.

[130]  J. Dorca,et al.  Risk stratification and prognosis of acute cardiac events in hospitalized adults with community-acquired pneumonia. , 2013, The Journal of infection.

[131]  S. Francis,et al.  Mechanistic links between acute respiratory tract infections and acute coronary syndromes. , 2013, The Journal of infection.

[132]  F. Tubach,et al.  Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. , 2013, Evidence-based child health : a Cochrane review journal.

[133]  Brian A. King,et al.  Current cigarette smoking among adults - United States, 2011. , 2012, MMWR. Morbidity and mortality weekly report.

[134]  J. Maurer Severity assessment tools to guide ICU admission in community-acquired pneumonia: systematic review and meta-analysis , 2012 .

[135]  H. Imaoka,et al.  Azithromycin and the risk of cardiovascular death. , 2012, The New England journal of medicine.

[136]  Sara E Cosgrove,et al.  Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[137]  R. Leggiadro Bacterial Coinfections in Lung Tissue Specimens from Fatal Cases of 2009 Pandemic Influenza A (H1N1) – United States, May–August 2009 , 2010 .

[138]  R. Balk SMART-COP: A Tool for Predicting the Need for Intensive Respiratory or Vasopressor Support in Community-Acquired Pneumonia , 2009 .

[139]  D. Musher,et al.  The History of Pneumococcal Disease , 2008 .

[140]  K. Strålin Usefulness of aetiological tests for guiding antibiotic therapy in community-acquired pneumonia. , 2008, International journal of antimicrobial agents.

[141]  T. Marrie,et al.  Etiology of community-acquired pneumonia treated in an ambulatory setting. , 2005, Respiratory medicine.

[142]  M. Kolczak,et al.  Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. , 2000, The New England journal of medicine.

[143]  R. Speich,et al.  Shortcomings of chest radiography in detecting Pneumocystis carinii pneumonia. , 1994, Journal of acquired immune deficiency syndromes.

[144]  J T Macfarlane,et al.  Comparative clinical and laboratory features of legionella with pneumococcal and mycoplasma pneumonias. , 1987, British journal of diseases of the chest.

[145]  H. Reynolds,et al.  Changing spectrum of pneumonia--news media creation or clinical reality? , 1983, The American journal of medicine.

[146]  R. Heffron Pneumonia, with special reference to pneumococcus lobar pneumonia , 1939 .